Targovax ASA logo

TRVX - Targovax ASA News Story

NOK8 0.2  2.6%

Last Trade - 25/09/20

Sector
Healthcare
Size
Micro Cap
Market Cap £49.0m
Enterprise Value £46.0m
Revenue £234k
Position in Universe 990th / 1782

Targovax ASA: Annual Report 2016

Wed 15th March, 2017 8:16pm
Targovax ASA: Annual Report 2016

On 15 March 2017, the Board of Directors of Targovax ASA approved the financial statements for 2016 for issuance, subject to approval by the Annual General meeting on April 5, 2017.

Please find attached the Annual Report with financial statements for 2016.

For further information, please contact:
Renate Birkeli, Investor Relations
Phone: +47922 61 624
Email: renate.birkeli@targovax.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Targovax ASA via Globenewswire

© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.